ArticleEmerging infectious diseases2017
Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers.
Article in Emerging infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Ebola laboratory preparedness at frontline hospitals: can we or can't we?Journal of clinical microbiology · 2026Article
- A narrative review of high-level isolation unit operational and infrastructure features.BMJ global health · 2023Review
- Biosafety and infectious disease occupational health training from the NIEHS Worker Training Program: A historical look at capacity building that supported a COVID-19 response.Journal of emergency management (Weston, Mass.) · 2022Article
- Update on Ebola Treatment Center Costs and Sustainability, United States, 2019.Emerging infectious diseases · 2020Article
- Intensive Care Unit Preparedness During Pandemics and Other Biological Threats.Critical care clinics · 2019Review
- Consequences of delays and imperfect implementation of isolation in epidemic control.Scientific reports · 2019Article
- U.S. High-Level Isolation Unit Clinical Laboratory Capabilities Update.Journal of clinical microbiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To identify barriers to maintaining and applying capabilities of US high-level isolation units (HLIUs) used during the Ebola virus disease outbreak, during 2016 we surveyed HLIUs. HLIUs identified sustainability challenges and reported the highly infectious diseases they would treat. HLIUs expended substantial resources in development but must strategize models of sustainability to maintain readiness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.